Daxor Corporation Asset Resilience Ratio

Latest as of December 2011: 65.10%

Daxor Corporation asset resilience ratio. Daxor Corporation (DXR) has an Asset Resilience Ratio of 65.10% as of December 2011. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Daxor Corporation (DXR) defensive interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$55.80 Million
Cash + Short-term Investments

Total Assets

$85.72 Million
All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio of Daxor Corporation (2000–2011)

Asset resilience ratio of Daxor Corporation from 2000 to 2011. This chart shows how Daxor Corporation's Asset Resilience Ratio has changed over time. Read Daxor Corporation balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Daxor Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Daxor Corporation's balance sheet.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $55.80 Million 65.1%
Total Liquid Assets $55.80 Million 65.10%

Asset Resilience Insights

  • Very High Liquidity: Daxor Corporation maintains exceptional liquid asset reserves at 65.10% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Daxor Corporation Industry Peers by Asset Resilience Ratio

Compare Daxor Corporation's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Caina Technology Co. Ltd.
SHE:301122
Medical Instruments & Supplies 19.55%
Austco Healthcare Ltd
AU:AHC
Medical Instruments & Supplies 15.90%
Nyxoah
BR:NYXH
Medical Instruments & Supplies 12.40%
Ocumetics Technology Corp
V:OTC
Medical Instruments & Supplies 0.00%
Osteopore Ltd
AU:OSX
Medical Instruments & Supplies 22.60%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 7.53%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 46.84%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 3.36%

Daxor Corporation Asset Resilience Ratio by Year (2000–2011)

Daxor Corporation asset resilience ratio by year from 2000 to 2011. The table below shows the annual Asset Resilience Ratio data for Daxor Corporation.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2011-12-31 65.10% $55.80 Million $85.72 Million +6.02pp
2010-12-31 59.08% $53.88 Million $91.20 Million -11.77pp
2009-12-31 70.85% $53.27 Million $75.19 Million -18.10pp
2008-12-31 88.96% $68.34 Million $76.82 Million +15.91pp
2007-12-31 73.05% $74.92 Million $102.56 Million -12.63pp
2006-12-31 85.67% $66.97 Million $78.17 Million -10.43pp
2005-12-31 96.11% $57.25 Million $59.57 Million -1.89pp
2004-12-31 97.99% $54.81 Million $55.93 Million -0.14pp
2003-12-31 98.14% $47.40 Million $48.30 Million +0.54pp
2002-12-31 97.59% $40.57 Million $41.57 Million +0.51pp
2001-12-31 97.09% $42.27 Million $43.54 Million -1.19pp
2000-12-31 98.28% $48.72 Million $49.58 Million --
pp = percentage points

About Daxor Corporation

NASDAQ:DXR USA Medical Instruments & Supplies
Market Cap
$50.70 Million
Market Cap Rank
#21647 Global
#4848 in USA
Share Price
$8.70
Change (1 day)
-3.33%
52-Week Range
$8.70 - $14.75
All Time High
$23.78
About

Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corpo… Read more